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As developments progress in the understanding and treatment of diabetes, we take a moment to reflect on the Journal as it enters its 10th year. It has been a decade of tremendous change. In 2009, the diabetes community was recovering from the shock of ACCORD trial: 257 deaths over 3.5 years with an achieved HbA1c of 6.4% among 5128 intensively treated the high cardiovascular (CV) risk patients, compared with 203 deaths with an achieved HbA1c of 7.5% among 5123 having "standard treatment." Today, we see evidence of reduction in CV outcomes with a variety of treatments, including thiazolidinediones, sodium-glucose transport inhibitors, and glucagon-like peptide-1 receptor agonists, suggesting that some of the adverse effects seen in ACCORD were related to older approaches to treatment, and that new approaches may offer new paradigms (Fig. ). [Figure: see text] The Journal has published nearly 800 papers (Fig. a), with contributions from 86 countries, on topics ranging from treatment approaches, to effects of sleep abnormality, to cost issues and epidemiologic patterns, to patterns of fat distribution, to diabetic neuropathy, nephropathy, and retinopathy, to CV conditions, to dyslipidemia, to obesity, to insulin secretory function, to exercise, to diet, to supplements and herbal treatments, to infections, to malignancy, to adherence and psychosocial factors… and the list goes on, reflecting the tremendous complexity of the condition and its implications. The ongoing interest in these publications has been gratifying, and we are happy that in 2017 more than 100 000 article downloads had been registered (Fig. b) and that in 2016 there were more than 1100 citations of articles in the Journal, giving us an Impact Factor of 3.039. [Figure: see text] , the journey of a thousand miles begins with a single step, and we have taken many small steps to reach Volume 10. As we begin Volume 10, we thank all those whose contributions to the Journal have been crucial to its success: our authors, our reviewers, our fellow editors, and, most importantly, our readers.